Andres Rodriguez Ruiz

Andres Rodriguez Ruiz

Auto-generated profile, based on publicly available information

Andres Rodriguez Ruiz

Department of Neurology, Emory University, Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in JAMA Neurology
Verified
Journal Article
Closed access
PDF file
ARAndres Rodriguez Ruiz
Andres Rodriguez Ruiz
JVJan Vlachy
Jan Vlachy
JLJong Woo Lee
Jong Woo Lee
EGEmily J. Gilmore
Emily J. Gilmore
TATurgay Ayer
Turgay Ayer
FCfor the Critical Care EEG Monitoring Research Consortium
for the Critical Care EEG Monitoring Research Consortium
Importance Periodic and rhythmic electroencephalographic patterns have been associated with risk of seizures in critically ill patients. However, specific features that confer higher seizure risk remain unclear. Objective To analyze the association of distinct characteristics of periodic and rhythmic patterns with seizures. Design, Setting, and Participants We reviewed electroencephalographic recordings from 4772 critically ill adults in 3 academic medical centers from February 2013 to September 2015 and performed a multivariate analysis to determine features associated with seizures. Interventions Continuous electroencephalography. Main Outcomes and Measures Association of periodic and rhythmic patterns and specific characteristics, such as pattern frequency (hertz), Plus modifier, prevalence, and stimulation-induced patterns, and the risk for seizures. Results Of the 4772 patients included in our study, 2868 were men and 1904 were women. Lateralized periodic discharges (LPDs) had the highest association with seizures regardless of frequency and the association was greater when the Plus modifier was present (58%; odds ratio [OR], 2.00,P < .001). Generalized periodic discharges (GPDs) and lateralized rhythmic delta activity (LRDA) were associated with seizures in a frequency-dependent manner (1.5-2 Hz: GPDs, 24%,OR, 2.31,P = .02; LRDA, 24%, OR, 1.79,P= .05; ≥ 2 Hz: GPDs, 32%, OR, 3.30,P< .001; LRDA, 40%, OR, 3.98,P< .001) as was the association with Plus (GPDs, 28%, OR, 3.57,P< .001; LRDA, 40%,P< .001). There was no difference in seizure incidence in patients with generalized rhythmic delta activity compared with no periodic or rhythmic pattern (13%, OR, 1.18,P = .26). Higher prevalence of LPDs and GPDs also conferred increased seizure risk (37% frequent vs 45% abundant/continuous, OR, 1.64,P = .03 for difference; 8% rare/occasional vs 15% frequent, OR, 2.71,P = .03, vs 23% abundant/continuous, OR, 1.95,P= .04). Patterns associated with stimulation did not show an additional risk for seizures from the underlying pattern risk (P> .10). Conclusions and Relevance In this study, LPDs, LRDA, and GPDs were associated with seizures while generalized rhythmic delta activity was not. Lateralized periodic discharges were associated with seizures at all frequencies with and without Plus modifier, but LRDA and GPDs were associated with seizures when the frequency was 1.5 Hz or faster or when associated with a Plus modifier. Increased pattern prevalence was associated with increased risk for seizures in LPDs and GPDs. Stimulus-induced patterns were not associated with such risk. These findings highlight the importance of detailed electroencephalographic interpretation using standardized nomenclature for seizure risk stratification and clinical decision making.

1 December 2017 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
ASAaron F. Struck
Aaron F. Struck
BUBerk Ustun
Berk Ustun
ARAndres Rodriguez Ruiz
Andres Rodriguez Ruiz
JLJong Woo Lee
Jong Woo Lee
SLSuzette M. LaRoche
Suzette M. LaRoche
MWM. Brandon Westover
M. Brandon Westover
Continuous electroencephalography (cEEG) provides real-time monitoring of brain function in hospitalized patients. The use of cEEG is expanding, motivated by reports showing a high incidence of subclinical seizures in encephalopathic patients with conditions ranging from sepsis to traumatic brain injury.1-3

1 April 2020 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
ASAaron F. Struck
Aaron F. Struck
MTMohammad Tabaeizadeh
Mohammad Tabaeizadeh
SSSarah E. Schmitt
Sarah E. Schmitt
ARAndres Rodriguez Ruiz
Andres Rodriguez Ruiz
CSChrista B. Swisher
Christa B. Swisher
MWM. Brandon Westover
M. Brandon Westover
The use of continuous electroencephalogram (cEEG) monitoring in hospitalized patients has expanded markedly over the last decade.1,2 The growth is partially a response to evidence that subclinical or electrographic seizures are relatively common in hospitalized patients,3-10 including patients without a primary neurological diagnosis (10%-12%).11,12 Evidence supporting the importance of detecting and treating electrographic seizures comes from the association between electrographic seizures and worse neurological outcomes, including epilepsy.13-16 Indeed, cEEG has been found to be cost-effective17 and associated with decreased mortality.13

1 March 2021 in Journal Of Clinical Neurophysiology
Verified
Journal Article
Closed access
AMAnna-Marieta Moise
Anna-Marieta Moise
IKIoannis Karakis
Ioannis Karakis
AHAline Herlopian
Aline Herlopian
MDMonica Dhakar
Monica Dhakar
LHLawrence J. Hirsch
Lawrence J. Hirsch
ARAndres Rodriguez
Andres Rodriguez
Purpose: Autoimmune encephalitis (AE) is a cause of new-onset seizures, including new-onset refractory status epilepticus, yet there have been few studies assessing the EEG signature of AE. Methods: Multicenter retrospective review of patients diagnosed with AE who underwent continuous EEG monitoring. Results: We identified 64 patients (male, 39%; white, 49%; median age, 44 years); of whom, 43 (67%) were antibody-proven AE patients. Of the patients with confirmed antibody AE, the following were identified: N-methyl-D-aspartate receptor (n = 17, 27%), voltage-gated potassium channel (n = 16, 25%), glutamic acid decarboxylase (n = 6, 9%), and other (n = 4, 6%). The remaining patients were classified as probable antibody-negative AE (n = 11, 17%), definite limbic encephalitis (antibody-negative) (n = 2, 3%), and Hashimoto encephalopathy (n = 8, 13%). Fifty-three percent exhibited electrographic seizures. New-onset refractory status epilepticus was identified in 19% of patients. Sixty-three percent had periodic or rhythmic patterns; of which, 38% had plus modifiers. Generalized rhythmic delta activity was identified in 33% of patients. Generalized rhythmic delta activity and generalized rhythmic delta activity plus fast activity were more common in anti-N-methyl-D-aspartate AE (P = 0.0001 and 0.0003, respectively). No other periodic or rhythmic patterns exhibited AE subtype association. Forty-two percent had good outcome on discharge. Periodic or rhythmic patterns, seizures, and new-onset refractory status epilepticus conferred an increased risk of poor outcome (OR, 6.4; P = 0.0012; OR, 3; P = 0.0372; OR, 12.3; P = 0.02, respectively). Conclusion: Our study confirms a signature EEG pattern in anti-N-methyl-D-aspartate AE, termed extreme delta brush, identified as generalized rhythmic delta activity plus fast activity in our study. We found no other pattern association with other AE subtypes. We also found a high incidence of seizures among patients with AE. Finally, periodic or rhythmic patterns, seizures, and new-onset refractory status epilepticus conferred an increased risk of poor outcome regardless of AE subtype.

1 April 2017 in Clinical Neurophysiology
Verified
Journal Article
Closed access
VAVincent Alvarez
Vincent Alvarez
ARAndres A. Rodriguez Ruiz
Andres A. Rodriguez Ruiz
SLSuzette LaRoche
Suzette LaRoche
LHLawrence J. Hirsch
Lawrence J. Hirsch
CPChristopher Parres
Christopher Parres
JLJong Woo Lee
Jong Woo Lee

1 April 2016 in Journal Of Clinical Neurophysiology
Verified
Journal Article
Closed access
JLJong Woo Lee
Jong Woo Lee
SLSuzette LaRoche
Suzette LaRoche
HCHyunmi Choi
Hyunmi Choi
ARAndres A. Rodriguez Ruiz
Andres A. Rodriguez Ruiz
EFEvan Fertig
Evan Fertig
CHCecil D. Hahn
Cecil D. Hahn
Purpose: The rapid expansion of the use of continuous critical care electroencephalogram (cEEG) monitoring and resulting multicenter research studies through the Critical Care EEG Monitoring Research Consortium has created the need for a collaborative data sharing mechanism and repository. The authors describe the development of a research database incorporating the American Clinical Neurophysiology Society standardized terminology for critical care EEG monitoring. The database includes flexible report generation tools that allow for daily clinical use. Methods: Key clinical and research variables were incorporated into a Microsoft Access database. To assess its utility for multicenter research data collection, the authors performed a 21-center feasibility study in which each center entered data from 12 consecutive intensive care unit monitoring patients. To assess its utility as a clinical report generating tool, three large volume centers used it to generate daily clinical critical care EEG reports. Results: A total of 280 subjects were enrolled in the multicenter feasibility study. The duration of recording (median, 25.5 hours) varied significantly between the centers. The incidence of seizure (17.6%), periodic/rhythmic discharges (35.7%), and interictal epileptiform discharges (11.8%) was similar to previous studies. The database was used as a clinical reporting tool by 3 centers that entered a total of 3,144 unique patients covering 6,665 recording days. Conclusions: The Critical Care EEG Monitoring Research Consortium database has been successfully developed and implemented with a dual role as a collaborative research platform and a clinical reporting tool. It is now available for public download to be used as a clinical data repository and report generating tool.